Search 1
Entities
LogoName Σ Employees
Beta Innov Beta Innov

[Automatic translation follows] Development of innovative drugs with curative potential in Immunology and Cancerology. Beta Innov SAS is an innovative pharmaceutical Research and Development company, created in March 2009 by patient families. Beta Innov aims to achieve a major therapeutic leap in the treatment of autoimmune diseases and Glioblastoma by using a physiological (Immunology) or metabolic (Glioblastoma) approach avoiding the costs of gene therapies and the adverse effects of therapies. by antibodies.

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 14
Sinnovial SAS Sinnovial SAS

[Automatic translation follows] Sinnotest® supports rheumatologists in optimizing the prescription of biotherapies in rheumatology SINNOVIAL is a biotechnology company that develops personalized medicine devices to improve the management of Chronic Inflammatory Rheumatism (RIC) in Rheumatology (rheumatoid arthritis, ankylosing spondylitis, in particular). Our mission: to improve the quality of life of patients by maximizing the chances of success of their treatment with biotherapy. Our objective: to provide the doctor with a device to assist in therapeutic orientation which allows him, in real time, to optimize the selection of biotherapy. “The right treatment, to the right patient, at the right time!” » …

Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology

2 1 1 4
Gecko Biomedical Gecko Biomedical

Gecko Biomedical is a fast-paced medical device company, dedicated to the development of innovative tissue reconstruction solutions. We are leveraging our technology platforms to develop novel solutions to disrupt the field of surgery and positively impact the life of patients.

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 4
PHARNEXT PHARNEXT

New therapies for neurodegenerative diseases Pharnext is an advanced clinical-stage biopharmaceutical company developing novel therapeutics for neurodegenerative diseases that currently lack curative and/or disease-modifying treatments. Pharnext has two lead products in clinical development. PXT3003 completed an international Phase III trial with positive topline results for the treatment of Charcot-Marie-Tooth disease type 1A (‘CMT1A’) and benefits from orphan drug status in Europe and the United States. An international pivotal Phase III study of PXT3003 in CMT1A, the PREMIER trial, is currently ongoing. PXT864 has generated encouraging Phase II results in Alzheimer’s disease and will be advanced through partnerships. Both of Pharnext’s …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 2 30
CERTIS Therapeutics CERTIS Therapeutics

Disruptive solutions for image guided therapies Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care. medical device, oncology, cardiology, MRI guided, and Thermal ablation

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

3 3 0 18
Corlieve Therapeutics Corlieve Therapeutics

At Corlieve, we are focused on bringing novel therapeutic options to patients with severe neurological disorders. Corlieve Therapeutics, a fully owned subsidiary of UniQure, is a biotechnology company focused on bringing novel therapeutic options to patients with severe neurological disorders.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 2 0 3
BIOTIS Bordeaux BIOTIS Bordeaux

Laboratory for the Bioengineering of Tissues (Mixed Research Unit: Inserm and Bordeaux University) The BioTis laboratory (Laboratoire de Bioingénierie Tissulaire – Laboratory for the Bioengineering of Tissues) is a “Mixed Research Unit” (#1026) that is comprised of personnel from the INSERM, the French national institute of health and medical research), and from the University of Bordeaux. The Unit is located on the 5th floor of the new Bordeaux Biologie Santé (BBS) building at the University of Bordeaux medical campus. BioTis has around 65 members including full time researchers, junior and senior professors in medicine/medical sciences, technical and support staff, post-doc …

Type: Public Research & Education Startup Activities: deeptech Technologies: Synthetic Biology

1 1 0 21
Emopsy Emopsy

[Automatic translation follows] By mixing the scientific and the clinical, emopsy offers new tools for evaluating and supporting emotional skills for psychologists.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

12 2 0 2
BoneTag BoneTag

Reinventing orthopedics BoneTag is a french start-up, based in Montpellier, which is focused on the development of innovative medical devices in orthopedics. BoneTag is developing two medical devices: • INCESSU: A solution making total knee arthroplasties (TKA) smart and connected. This medical device allows the communication between the implanted TKA and the surgeon. The communicated data are: identification information about the TKA, temperature in contact with the bone and motion between the TKA and the bones. • KNEEMATICS: A dynamic 3D representation of the kinematics of total knee arthoplasties. This device allows the visualization in real-time, and in 3D, of …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology IoT

1 1 0 5
MAAsiRNA MAAsiRNA

MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). A significant challenge in the field of nervous system pathologies lies in the absence of effective treatments. MAAsiRNA develops a pioneering targeted therapy utilizing small interfering RNA (siRNA). After over a decade of intensive interdisciplinary research, we have successfully developed a siRNA-based treatment for Charcot-Marie-Tooth disease type 1A (CMT1A), the most prevalent form of hereditary peripheral neuropathy. CMT1A affects 1 in 5000 people, comprising a total of 1.5 million individuals worldwide. Our current objective is to advance towards a patient-ready therapy. Our innovative therapeutic approach has the potential to …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 1 0 3
Blue Bees Therapeutics Blue Bees Therapeutics

Blue Bees Therapeutics develops immunomodulatory proteins with therapeutic potential to fight cancer Blue Bees Therapeutics is a biotechnology company founded in March 2022, dedicated to the development of first-in-class immunotherapies for the treatment of cancers, based on a breakthrough technology discovered by the team led by Dr Michel Léonetti, within the Department of Pharmacology and Immunoanalysis from CEA Paris-Saclay. This technology allows to generate antibodies stimulating the anti-tumor immune response via a double cell receptor targeting coupled with heparan sulphate proteoglycans (HSPG). Immunothérapie, Immuno-oncologie, pharma, Biotech, Immunologie, Oncologie, Cancer, Médicament, and Drug

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 2 0 8
Diotheris Diotheris

Diotheris develops anti-infective microbes to prevent bacterial infections and act against antibiotic resistance We create bacterial therapies of the human skin and mucosal microbiome against pathogenic bacteria. Our first suite of products (NASOFLORE line) targets Staphyloccocus aureus / MRSA (Methicillin resistant S aureus). The products based on live bacteria identified in our clinical and in vitro studies do not generate emergence of antibiotic resistance. antimicrobial, nose microbiome, therapeutics, LBP, Staphylococcus Aureus, and MRSA

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

1 1 0 1
Deeptope Deeptope

Advanced Antibody Expertise Deeptope's expertise lies in antibody charaterisation (epitope/paratope mapping) and optimisation using high throughput methods. antibody, paratope mapping, epitope mapping, and antibody optimisation

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

1 1 0 7
Kimialys Kimialys

Innovative biosensing solutions for diagnostic and pharmaceutical companies, leveraging our K-One® surface chemistry. We are a team of chemists and biosensor engineers gathered around a common mission: shaping the future of biodetection for a better world. Kimialys is the result of 10 years of meticulous academic research in surface chemistry. Controlling what is happening on the surface is a fundamental aspect of biosensing techniques such as rapid tests, point-of-care diagnostics, and real-time sensors. Without the right surface interactions, even the most advanced biosensors can falter, leading to misleading results. Our research efforts have always been to optimize these crucial parameters, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

7 4 2 15
Sirius NeoSight Sirius NeoSight

[Automatic translation follows] New view for cancer therapeutics Sirius NeoSight is an innovative technological breakthrough company which aims to become a key player in the detection of subclinical neo-cancers, relapses and therapeutic monitoring of patients, thus offering doctors a new perspective on the therapeutic effectiveness implemented. . Sirius NeoSight uses breakthrough patented technology from a consortium of academic laboratories with expertise in the field.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

14 4 6 4
EYE TECH CARE EYE TECH CARE

Ultrasound Cyclo Plasty = Focused, Adaptable, Proven EYE TECH CARE, based in Lyon, was founded in 2008 by experts in the field of therapeutic ultrasound. The company develops and markets medical devices for the non invasive treatment of eye diseases. Glaucoma and ocular hypertension affect some 12O million people around the world, but are diagnosed in only about 30% of cases. It is the second cause of blindness, according to WHO (World Health Organization). With the support of renowned scientific and financial partners, EYE TECH CARE has developed the EyeOP1, an unique therapeutic device. Its teams have designed the only …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

2 2 0 30
Oncofactory Oncofactory

🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 1 2 8
Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI) Laboratoire de Biologie Tissulaire et Ingénierie thérapeutique (LBTI)

Explore Understand Innovate LBTI is a leading French research laboratory specializing in the study of healthy and diseased tissues and in the development of innovative therapeutic strategies with high potential for translation toward clinical applications. We have strong expertise in human skin, cartilage and mucosae. Our specific research aims are: > to analyze the basic mechanisms of tissue organization and homeostasis, and to identify potential therapeutic targets > to understand and model the tissue response to physiological or pathological stress (including mechanical stress and aging) > to develop novel therapeutic approaches for tissue repair and targeted delivery of therapeutic agents …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 2 1 43
DimiCare Biotech DimiCare Biotech

goes FAR BEYOND (Fighting Antimicrobial Resistance to the Biological EmergencY to Opportunistic and Neglected Diseases) Dimicare Biotech is a project from INSERM and Université Côte d'Azur focused on the development of novel "precision" antimicrobial drugs to fight multidrug-resistant infections. Our main project focuses on the development of a new treatment against multidrug-resistant S. aureus strains (including the WHO priority MRSA; methicillin-resistance S. aureus strains). Currently, this treatment is in the early-preclinical phase where its efficacity against several clinical strains and its innocuity in Human cells has been confirmed. Dimicare Biotech is building a great team involving Microbiology Medical doctors, Fundamental …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

7 2 0 N/A
NERVOSAVE THERAPEUTICS NERVOSAVE THERAPEUTICS

Innovative therapies for peripheral nerve diseases Nervosave Therapeutics discovers and develops therapies that slow, stop and reverse a broad range of demyelinating peripheral nerve diseases. Our first aim is to develop best in class Gene Therapy for CMT1A patients and beyond for all demyelinating CMT diseases. We develop robust discovery programs targeting both CMT diseases and acquired demyelinating peripheral neuropathies such as diabetic peripheral neuropathy and Guillain-Barré syndrome.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

3 1 0 4
Stent Up Stent Up

Stent'Up vise à sécuriser le traitement préventif des anévrismes cérébraux par la création d'un implant révolutionnaire. Stent Up, designs, manufactures, and markets medical devices dedicated to the treatment of strokes.

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

8 1 7 6
Catsalyze Catsalyze

We improve your enzymes. Catsalyze will revolutionize enzymatic biocatalyze. Our proprietary technology allows us to graft enzymes around a protein ring, which gives them strong advantages such as increased stability, solubility, efficiency but also the possibility of assembling these grafted rings to create perfectly colocalized enzymatic cascades. . So extremely effective. Our challenge? Transform biomass in a gentle and clean way and through accelullar enzymatic catalysis into chemical bricks classically petrosourced and synthesized with pollution. The future of chemistry passes through Catsalyze.

Type: Startup Activities: deeptech greentech Technologies: Synthetic Biology

25 4 22 2
Cell&Soft Cell&Soft

Soft culture plates for pleased cells Cell&Soft is a young french biotech located in the AURA region, in Grenoble city. Born from a joint project between LTM Lab (CNRS) and CEA BIG, Cell&Soft is specialized in the development, production and sale of soft and biomechanical substrates for in vitro cell culture. Cell&Soft offers solutions to enhance the physiology and the relevance of cell culture and cell-based assays. biotechnology, cell culture, soft substrates, culture plates, cell-based assays, biotech, in vitro, drug discovery, stem cells, controlled rigidity, controlled stiffness, and petri dish

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

4 3 1 5
DreaminzZz DreaminzZz

With HYPNOS, we have created the no medical drugs therapy of the future, to get rid of medical drugs like sleeping pills You can discover HYPNOS, the first hypnotic mask connected to an application. This innovative project, Made in France, puts hypnosis available to everyone in order to contribute to our wellbeing. Thanks to HYPNOS, you can improve your sleep, handle your daily stress, reduce your pain and improve your motivation. Behind this incredible project, there are 2 mens : Kevin Kastelnik and Guillaume Gautier. Kevin is engineer and crazy about new technology and Guillaume is Practitioner of Ericksonian Hypnosis. …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

3 2 1 9
Diamidex Diamidex

Make Visible the Invisible Faster to Make your World Safer Founded in 2014, DIAMIDEX (Diagnostic Microbiology Express) is an innovative company specialized in the detection and quantification of microorganisms of interest. Its mission: making the invisible visible faster, to make your world safer. Its patented innovative technological approach brings about a major breakthrough to meet the speed and technicality challenges arising from microbiological culture. Based on a powerful technological platform, recognized by the scientific and industrial communities, DIAMIDEX offers and develops turnkey test solutions, which can be used in both laboratories and in the field to obtain a quantitative count …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

12 6 8 25
Pili Pili

carbon conscious color company Pili, carbon conscious color company Pili is the leader in bio-based colorants and pigments. Its unique fermentation and sustainable chemistry processes, enable the production of high-performance, and low-carbon colors. Its technology aims at decarbonizing the color industry by drastically reducing the use of chemicals and fossil resources, particularly oil. Its products are designed for the textile, inks, paints & coatings and plastics sectors. Founded in 2015, Pili operates from 3 different sites: Toulouse White Biotechnology (TWB), Paris and the Roches-Roussillon industrial platform in Isère. With around 40 employees to date, the company has invested over €35 …

Type: Startup Activities: biotech deeptech manufacturing Technologies: Bio sourced materials Synthetic Biology

17 10 8 52
SYNTHELIS SYNTHELIS

Cell-free systems expert ! The futures of protein ! Best chance for your protein projects ! A French biotech company located in Grenoble, at the heart of the French Alps, Synthelis is the leading French expert in Cell-Free systems. Our proprietary cell-free expression technology has established itself as a benchmark across Europe and is now on a path to compete with US leaders in the field. The need to produce every possible type of protein quickly, reliably and economically is a real challenge in research fields today, and it will become increasingly important to industry in the decades to come. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

12 3 11 7
Eurofins CALIXAR Eurofins CALIXAR

Native and functional membrane therapeutic targets for improving Drug and Vaccine Discovery To contact us : contact@calixar.com CALIXAR, is a biotech company specialized in the functional and native isolation of complex membrane therapeutic targets and antigens. We develop and implement chemistry and biochemistry tools to isolate in solution - with the highest purity levels - full-length membrane proteins, while keeping their structural and functional integrity. Our approach represents the opportunity for pharmaceutical companies to start and work with high quality targets or antigens before developing antibodies, formulating vaccines and/or discovering a primary lead through Structure Based Drug Design or High …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

11 6 7 18
CYTOO CYTOO

CYTOO is a preclinical stage drug discovery company specialized in muscular and neuromuscular disorders. CYTOO partners its versatile patient-derived muscle drug discovery engine to pharma and biotech companies and develops its own drug candidates. CYOO has developed a fully mature human in vitro muscle model (MyoScreen) derived from primary human samples (healthy and pathological myoblasts) for generating NCEs from a variety of pathological conditions (rare, chronic). Core expertise lies on in vitro muscle regeneration, contraction, hypertrophy, and metabolism. High Content Analysis, High Content Screening, Drug Discovery, Physiological, preclinical, muscular and neuromuscular disorders, and muscle health

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

2 1 0 34
Notify Therapeutics Notify Therapeutics

Novel treatment paradigm for infertile women. Through targeting of the early and hormone-independent phase of egg maturation, we aim at developing a first-in-class treatment for infertile women, who do not benefit from standard hormone therapy.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

0 0 0 8
BioTek Instruments BioTek Instruments

BioTek is worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. BioTek, now a part of Agilent Technologies, is a worldwide leader in the design, manufacture, and distribution of innovative life science instrumentation. Our comprehensive product line includes cell imaging systems, microplate readers, washers, dispensers, automated incubators, stackers and pipetting systems. These products enable life science research by providing high performance, cost-effective analysis and quantification of biomolecules, biomolecular interactions and cellular structure and function across diverse applications. Life Science instrumentation and automation and software.

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 188
DIVA Expertise DIVA Expertise

[Automatic translation follows] DEEP INNOVATION we adipose tissue. Research partner from the cell to Humans DIVA. Expertise is a scientific research consulting, strategy and development company in the fields of Health, Nutrition, Cosmetics and Aesthetics. Its objectives are to support manufacturers in the structuring, organization and development of their research in order to optimize costs, deadlines and results. Personalized support from our experts boosts the R&D process of a product by promoting Creativity, Innovation and Collaboration. Its core expertise is focused on the biology of so-called adipose tissue, recognized as an endocrine organ with a fundamental and central role in …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

3 0 3 5
CSV Experts CSV Experts

Always Meeting the Standards Computerized Systems Validation Experts. Consultancy services for healthcare regulated companies with regards computerized systems validation in GXP environments. The most valued services delivered in compliance with EU GMP and 21 CFR Part 11. Contact at info@csvexperts.com Strategies for the fulfillment of the GMP and GDP regulations, Strategies for the fulfillment of regulatory needs and quality assurance in the areas of R&D, Medical Devices, IT Compliance, Audits, and Business training

Type: Startup Activities: deeptech healthtech IT Services Technologies: Synthetic Biology

2 1 0 6
McSAF McSAF

Chemical tools for bioconjugaison & biodrugs McSAF is a Deeptech company specialized in Bio-Organic & Bio-Conjugates Chemistry, developing innovative technologies for improved targeted therapies. Its core expertise covers Therapeutic Peptides and Proteins, Antibodies, and Drug Conjugates. The team has a strong background in synthetic selective chemistry, and a real expertise in bioconjugation, including specific designs of Antibody Drug Conjugates (ADCs) with own proprietary coupling technology. Plus, the company has now a pipeline of three products in oncology incorporating McSAF Inside technology with the ambition to bring new biodrugs on the market solving unmet medical needs. Bioconjugation, Biopharmaceuticals, Antibody Drug Conjugates, …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 1 0 6
Medfield Diagnostics AB Medfield Diagnostics AB

Medfield Diagnostics AB develops medical devices based on microwave technology. Medfield Diagnostics AB (publ) aims to facilitate a device for decision-support to assist in clinical evaluation and triage of suspected intracranial injuries in the acute situation. This eliminates suffering of affected patients and leads to cost savings due to reduced healthcare and rehabilitation costs. The microwave diagnostic technology can monitor changes and generate images of tissue in the human body. There are many areas where the technology can be valuable, from detecting bleedings and tumors to internal temperature measurements. Microwave diagnostic instruments can be compact compared to other diagnostic techniques, …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

1 1 0 11
Medical Device Manufacturing Centre Medical Device Manufacturing Centre

Supporting medical device innovation, from concept to commercialisation. The Medical Device Manufacturing Centre (MDMC) project is currently funded by Scottish Enterprise. During the period of 2020-June 2023, this project was part-funded by the 2014–2020 European Structural and Investment Fund, the Edinburgh and South East Scotland City Deal and Heriot-Watt University. The Scottish Government is the Managing Authority for the European Structural Funds 2014-20 Programme. medical device manufacture

Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology

2 0 2 7
LTS Lohmann Therapie-Systeme AG LTS Lohmann Therapie-Systeme AG

We CARE. We CREATE. We DELIVER. We CARE. We CREATE. We DELIVER. The driving philosophy behind LTS LOHMANN Therapie-Systeme AG. As a trusted technology partner for the pharmaceutical industry, we develop and manufacture innovative drug delivery systems such as Transdermal Patches (“TTS”) and Oral Thin Films (“OTF”) as well as wearable drug delivery devices (“OBDS”). LTS ́ commercial offering encompasses more than 20 marketed products and a diverse pipeline of more than 40 development projects targeting multiple disease indications. LTS’s innovation pipeline contains both partner-funded as well as proprietary, LTS-funded projects. LTS maintains its leading position through the continuous refinement …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

0 0 0 289
Aseptix Health Sciences N.V. Aseptix Health Sciences N.V.

Aseptix Health Sciences is a global leader in next generation antimicrobials, specializing in novel and patented infection prevention products and technologies for medical, professional and consumer use. Aseptix’ sustainable antimicrobial technologies enable products to safely, effectively and quickly kill contagious pathogens and are used in a wide range of applications, industries and therapeutic areas. The Company markets its products and technologies through a combination of Aseptix branded and third party branded products, and licenses on its portfolio of patented technologies to global industry leaders in their markets. The corporate mission is to become the global alternative for user unsafe and …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 6
Mithra Mithra

Transforming Women’s Health Through Innovation Mithra (Euronext: MITRA) is a Belgian biotech company dedicated to transforming Women’s Health by offering new choices through innovation, with a particular focus on contraception and menopause. Mithra’s goal is to develop products offering better efficacy, safety and convenience, meeting women’s needs throughout their life span. Mithra explores the potential of the unique native estrogen estetrol in a wide range of applications in women health and beyond. After having successfully launched the first estetrol-based product in 2021, the contraceptive pill Estelle®, Mithra is now focusing on its second product Donesta®, the next-generation hormone therapy. Mithra …

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

1 0 1 553
BDD BDD

A World Class Drug Delivery Company BDD combines drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and create new value-added products. Rapid parallel clinical testing with BDD SWIFT significantly reduces the time from product concept to clinical success. Recognizing that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers. Our patented delayed release technology OralogiK provides unrivalled control of drug release at the right place and time. Our clinical division provides a full clinical package, including protocol development, study documentation design and regulatory authority …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 44
ANGLE ANGLE

The leading experts in cancer cell capture and analysis from liquid biopsies ANGLE is a world-leading liquid biopsy company with innovative circulating tumour cell (CTC) diagnostic solutions for use in research, drug development and clinical oncology using a simple blood sample. ANGLE's FDA cleared and patent protected circulating tumour cell (CTC) harvesting technology known as the Parsortix® PC1 System enables complete downstream analysis of the sample including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. ANGLE’s commercial businesses are focusing on diagnostic products and clinical services. Diagnostic products include the Parsortix® system and associated consumables. …

Type: SMB Activities: biotech healthtech deeptech Technologies: Synthetic Biology

1 1 0 158
Amarin Corporation Amarin Corporation

Amarin Corporation plc is a biopharmaceutical company focused on therapeutics to improve cardiovascular health. Amarin is an innovative pharmaceutical company leading a new paradigm in cardiovascular disease management. We are committed to increasing the scientific understanding of the cardiovascular risk that persists beyond traditional therapies and advancing the treatment of that risk for patients worldwide. Amarin has offices in Bridgewater, New Jersey in the United States, Dublin in Ireland, Zug in Switzerland, and other countries in Europe as well as commercial partners and suppliers around the world. For more information, visit www.amarincorp.com. See our Community Guidelines: bit.ly/2L7xEW6 Cardiovascular

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

1 0 1 456
SPINEART SPINEART

QUALITY - INNOVATION - SIMPLICITY Spineart is a privately held medical device company focused on simplifying the surgical act by designing, developing and promoting safe and efficient solutions to spine surgeons, operating room teams, and patients. Spineart is a pioneer in its field, having introduced unique patented and clinically validated technologies in the fields of Minimally Invasive Surgery, Motion Preservation, Fusion, Biologics, and Fractures Treatment. Spineart markets a complete portfolio combining traceable barcoded sterile packed implants with compact instrument sets, thus proudly promoting greater safety, cost-efficiency, and compliance at the hospital. Intended for US audience Medical devices, Spine surgery, Orthopaedic …

Type: SMB Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

0 0 0 266
KOELIS KOELIS

Advancing Prostate Care KOELIS has assisted urologists and radiologists from around the world in their routine clinical practice since 2006, providing the latest technology for personalized prostate cancer planning and management, from biopsy to active surveillance and treatment. Focused on developing advanced, targeted and less invasive solutions, KOELIS is committed to creating and bringing to the market a new paradigm in prostate cancer care, where physicians can offer the most personalized answers to their patients, avoiding any under or overtreatment and preserving quality of life. Thanks to cutting-edge imaging tools like Trinity® cartographer, which combines multiple imaging modalities with full …

Type: SMB Activities: healthtech deeptech Technologies: Synthetic Biology

9 5 4 116
ProteoGenix ProteoGenix

Accelerate your way to the clinic ProteoGenix is a leading life sciences organization which provides services in molecular biology and immunology and in particular polyclonal and monoclonal antibody development, recombinant protein expression and purification, peptide synthesis as well as gene synthesis. ProteoGenix’s commitment to its clients is to ensure the access to comprehensive and integrated solutions to help our customers develop the tools they need to efficiently conduct their biology and research projects in a time effective manner. Beginning with the synthesis of the gene ProteoGenix develops all the materials required for immunoassay services. Proteogenix’s exceptional and functional expertise combined …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

1 1 0 41
MD Start MD Start

MD Start is a fund, a team of entrepreneurs and an incubator combined, aimed at transforming innovative ideas into medical realities. Our mission is to incubate medical device innovations to the point where proof-of-principle in patients is demonstrated, allowing for interest from traditional investors and our continued funding. Our team operates the projects and new companies to bridge the gap between science and clinical experience. We source innovations that are too early for large corporate or venture investors. These inventions arise from clinicians all over the world who do not wish to become entrepreneurs Our ambition is to turn these …

Type: Incubators & VCs SMB Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 4
Drugabilis Drugabilis

CRO specialized in pharmaceutical drugability for research Expertise in Human and Animal health solid form characterization and formulation development. We deliver both experimental support and consulting services to biotechnology and pharmaceutical companies, not-for-profit organizations and complementary CROs. We are member of the association AFSSI, 1st French research center in Life Sciences, as a founding member and member of the board of Directors. Since March 2019 Joel Vacus, Drugabilis CEO & CSO, is the President of AFSSI. https://www.afssi.fr/ Feel free to contact us in order to exchange about your preclinical drug development! contact@drugabilis.com Lead optimization, Formulation, and Physical form optimization

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

0 0 0 8
DIVERCHIM CDMO DIVERCHIM CDMO

API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 1 1 46
Yposkesi, an SK pharmteco company Yposkesi, an SK pharmteco company

Partnering to bring your cell and gene therapies to life! ***This page has moved and is no longer active. Please follow us @SK pharmteco for all company news and updates.*** Yposkesi, an SK pharmteco company, is one of Europe’s largest Contract Development and Manufacturing Organizations (CDMO) for gene therapy viral vector manufacturing. As a trusted partner for biotech and pharmaceutical companies seeking to advance clinical trials and commercialize new Advanced Therapy Medicinal Products (ATMPs), Yposkesi offers a full range of services in lentiviral vectors and AAV (Adeno-Associated Virus) cGMP manufacturing. Within its current 50,000 ft2 (approx. 5,000 m2) facility, Yposkesi …

Type: Media SMB Activities: deeptech biotech Technologies: Synthetic Biology

13 3 10 186
CREATEMPS CREATEMPS

[Automatic translation follows] Marking & assembly for precision industries CREATEMPS has specialized for more than 25 years in the field of precision marking and assembly, a recognized professional in marking on medical devices. Implantable or not, on silicones, polymers, metals and technical textiles, CREATEMPS masters all marking techniques: pad printing, screen printing, laser engraving, microdosing... Marking, Assembly, Milling, Laser, Screen printing, Medical devices, Aeronautics, Watchmaking, Pad printing, Ink, Implantable, Microdosing, Medical, and Iso 13485: 2016

Type: SMB Activities: healthtech deeptech nanotech Technologies: Synthetic Biology

3 3 0 6
Meletios Therapeutics Meletios Therapeutics

Fulfil the urgent, large and unmet medical need for antiviral molecules. Fulfil the urgent, large and unmet medical need for antiviral molecules. antiviral, biotech, and emergent disease

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

0 0 0 8
FRAFITO FRAFITO

Depuis 35 ans, la Société Frafito vous accompagne en vous proposant des gammes de dispositifs médicaux innovants With more than 30 Years of experience Frafito is specialized in the distribution and manufacture of Medical Devices for healthcare professionnals. Frafito is mainly selling to retailers in the French territory and has many well known brands in its portfolio. Medical Devices, Healthcare, and Medical

Type: SMB Activities: deeptech healthtech Technologies: Synthetic Biology

3 0 3 15
Neurinnov Neurinnov

Neurinnov is a company based out of Montpellier, Occitanie, France. Our aim is to restore human functions in people with functional deficiencies for better quality of life

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

4 2 2 10
Zymvol Biomodeling Zymvol Biomodeling

Accelerating enzyme discovery and design through computer simulations We are a biotech company that delivers tailor-made enzymes designed to outperform client's needs. At Zymvol we combine cutting edge technology with top scientific expertise to make biocatalysis available to everyone. We are a trusted partner that supports our customers in every stage of their bio-journey: from project definition and prioritization to the development and delivery of tailored enzymes. Our unique approach enables unparalleled accuracy and predictability, along with unprecedented speed. We are the perfect partner for companies aiming to maximize their return on investment and meet their timelines in biocatalysis development. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 4 2 32
AELIX Therapeutics AELIX Therapeutics

Developing novel vaccines to cure HIV infection AELIX Therapeutics is a clinical-stage biotechnology company based in Barcelona, Spain. It is focused on the development of a therapeutic HIV vaccine to be included in cure/eradication strategies. AELIX Therapeutics is a spin-off of HIVACAT, the Catalan public-private consortium conducting cutting-edge research in this field. AELIX holds a worldwide, exclusive license for the development and commercialization of the HTI immunogen.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

2 1 1 6
RheoDx RheoDx

Cloud Based Haematology Diagnostics Delivered aaS RheoDx is a diagnostics company committed to improving the quality of life of hematology patients and the efficiency in their clinical management. Develops an inexpensive medical device that monitors red blood cells conditions in less than five minutes with a drop. Its small size and simplicity allow to be used at the point-of-care and at home. Spin-off of the Centre Recerca Matemàtica (CRM), and incorporated in the Collider, the venture builder of tech transfer by Mobile World Capital Foundation. Medical Devices, In vitro diagnostics, Hematology, Point-of-care, Transfusions, and Blood cells conditions

Type: Startup Activities: deeptech healthtech Technologies: Synthetic Biology

3 1 0 3
fisio360 fisio360

[Automatic translation follows] At physio360 physiotherapy centers you will find specialized care only from physiotherapists The physio360 physiotherapy clinics put at your service modern facilities with the highest technology and certified physiotherapists with extensive experience and continued training. The philosophy of our center is to provide individualized and personalized treatment, since all pathologies are not the same nor do all people have the same needs. physiotherapy, Therapeutic Massage, Osteopathy, and franchise

Type: Startup Activities: healthtech Technologies: Synthetic Biology

0 0 0 12
Enzymlogic Enzymlogic

Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. Enzymlogic is a world leader in the kinetic profiling of compounds to facilitate drug discovery. As experts in the generation and interpretation of kinetic data, we pride ourselves on a proven track record of successful partnerships with worldwide organizations of all sizes, supporting them on a routine basis during the early phases of drug discovery. We use exquisitely tuned assays to deliver accurate, robust and reproducible kinetic data of the highest quality that enhances the identification of compounds with the greatest therapeutic potential. The insight …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 0 1 12
SOM Biotech SOM Biotech

Biopharmaceutical company focused on the accelerated development of drugs for orphan indications through AI technology SOM Biotech is a biopharmaceutical company focused on the accelerated discovery and development of therapies for orphan indications through a proprietary artificial intelligence-based drug discovery technology and developing strategic partnerships with major research centers and pharmaceutical companies. SOM AI PRO Technology is a proprietary AI-based validated drug discovery technology of SOM Biotech. After defining drug candidates through the technology, we successfully finished the Clinical Phase 2a of two drugs with very positive results. This will contribute to treating two relevant neurodegenerative diseases more effectively, meeting …

Type: Startup Activities: biotech deeptech legaltech Technologies: A.I. Synthetic Biology

2 1 1 15
BioExpert Network BioExpert Network

Revolutionise science with your knowledge The BioExpert Network, or BEN, is an exclusive network of experts in the sectors of health, biotechnology, life science and investment. Members have the opportunity to access and evaluate funding proposals for innovative research and development projects before anyone else, and help shape the future of life science and medicine. Proposals which receive the most positive evaluations, in terms of innovation, scientific validity, team and business potential have the opportunity to progress to a crowdfunding campaign with Capital Cell, the first online investment platform in Europe specialized in health and biotechnology. PhD level scientists, physicians, …

Type: Incubators & VCs Startup Activities: deeptech healthtech agritech biotech fintech Technologies: Synthetic Biology

1 0 1 249
NOVAMEAT NOVAMEAT

Plant-Based Meat, Reinvented 🥩🌱 At Novameat, we believe it is time to say goodbye to bland, uninspired plant-based meats that cannot match animal products in terms of taste, texture and aroma. Using unique and exclusive technology, we are rewriting the rulebook when it comes to providing whole cuts with minimal environmental impact, but maximum satisfaction. At Novameat, we cater for the planet and everybody on it. Our goal is to address humanity’s most pressing problems, climate change and biodiversity collapse, without compromising on the meat culinary experience we all know and love. Plant-based consumption just got a whole lot cooler. …

Type: Startup Activities: foodtech manufacturing Technologies: 3D Printing Bio sourced materials Synthetic Biology

1 1 0 33
Nostrum Biodiscovery Nostrum Biodiscovery

Rethink and Accelerate Let's imagine a company that is able to speed up and increase the accuracy of the studies prior to the commercialization of pharmaceutical and biotech products. A young enterprise based on front line research, specialized in cutting-edge bioinformatics and ready to apply supercomputing power to the prediction of drug-target interactions and to the optimization of enzymes involved in biotechnological processes. A company devoted to solve issues related to drug discovery, precision medicine and industrial enzymology. Rethink and accelerate, that’s what NBD is about. We estimate that our approach can definitely reduce the early-stage drug development by up …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

11 0 6 44
Future Port Future Port

Spreading positive vibes through global tech events and impact awards empowering youth for a better future. Future Port's mission is to present a positive vision of the future, and empower people with a bold mindset, exponential technology, and courage to start building a better tomorrow for everyone, through exciting events and communities. Despite the many challenges world faces today and how it is portrayed by media, we are living in the most extraordinary times in human history. As humankind, we objectively live longer, healthier, richer, and happier lives than ever. More than that, nobody before us had such powerful tools …

Type: Startup Activities: IT Services Technologies: Robotics Drones 3D Printing Affective Computing A.I. Blockchain/Cryptocurrency IoT New Materials Sensors Synthetic Biology VR

6 1 3 19
Walk With Path Limited Walk With Path Limited

Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. 🏔 Explore beyond possible. 🦿 Enhancing human life and shaping the future world by creating inclusive innovations to make a positive impact. Product design, Medical devices, Innovation design engineering, Innovation, Parkinson's, Diabetes, Gait disorders, Data science, and Remote monitoring

Type: Startup Activities: healthtech deeptech biotech Technologies: Synthetic Biology

11 6 7 13
Spindiag GmbH Spindiag GmbH

The infection control solution. Spindiag is a spin-off of Hahn-Schickard, one of the world’s leading research institutions for microsystems technology. Based on its patented microfluidic platform “LabDisk”, Spindiag develops an easy-to-use, compact, and automated point-of-care system for the broad, fast, and affordable screening for respiratory pathogens such as SARS-CoV-2 or drug-resistant pathogens. Behavior guidelines: https://www.spindiag.de/social-media-netiquette/ Impressum Spindiag GmbH Daniel Mark Engesserstr. 4a 79108 Freiburg Germany Email: info@spindiag.de Phone: +49 761 203 73246 Amtsgericht Freiburg im Breisgau HRB 714527 Tax ID number: DE305897842 point-of-care testing and in-vitro diagnostics

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

0 0 0 15
Novadiscovery Novadiscovery

Nova has built jinkō, a unique in silico clinical trial simulation platform to de-risk and accelerate clinical trials Nova provides its jinkō clinical trials simulation platform to biotech and pharma companies, academic research centers and not-for-profit organizations. Jinkō® unlocks the potential of modeling & simulation to de-risk and accelerate the R&D of new therapies for the benefit of patients: identify best responders, optimise the drug's regimen, generate synthetic control arms, explore research outcomes that might not be feasible with conventional trials. Predict trial outcomes before advancing to real-world clinical trials and ultimately design studies that are more likely to succeed …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

14 7 8 63
Push4m Push4m

[Automatic translation follows] Smart muscles for robotics & exoskeletons Created in 2016, Push4m is a deeptech which patented, after 5 years of R&D, biomimetic muscle, a component which imitates the swelling of human muscle and dramatically improves the efficiency of exoskeletons and robots/cobots. This new generation universal actuator allows self-adaptation to the resisting torque by multiplication of the motor torque or its speed. Through this slow motion, it allows the robotic machine to adapt to its environment and to the operator, in complete safety. And not the other way around as is currently the case. This significantly reduces the energy …

Type: Startup Activities: deeptech Industry 4.0 manufacturing transporttech Technologies: Robotics 3D Printing A.I. Bio sourced materials IoT Synthetic Biology

4 0 4 1
Alzohis Alzohis

Entreprise de dispositif médical de diagnostic in vitro : Noratest® In vitro diagnostic medical device Diagnostic, Innovation, Maladies neurodégénératives, Alzheimer, Neurosciences, Entreprise, and Entrepreneuriat

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 2
Carthera Carthera

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

24 11 13 27
TargEDys TargEDys

From Probiotics to PreciBiomics TargEDys is a French commercial-stage biotech company specialized in the development of precision probiotics, or PreciBiomic solutions. Our mission is to detect, transpose and make available microbiome-based innovations to answer global public health challenges. How? By translating microbiome fundamental research from prestigious French institutes such as the Inserm and IGFL to applied research in probiotics, understanding the molecular mechanism of action of our strains, and developing industrial processes and IP to propose turnkey science-backed probiotics. Our vision is to bring the microbiome to the heart of healthcare and harvest its immense potential to improve the quality …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

5 1 4 9
Poietis Poietis

Make tissues real Poietis (gr. Ποίησις: to make). "The one who makes things real."​ Poietis is a health-tech company specialized in the development of solutions for manufacturing human tissues by 4D Bioprinting. Poietis commercializes its Next Generation Bioprinting (NGB) systems for Cell Therapy & Research Centers and also develops advanced therapies with leading clinicians. 4D Bioprinting, Tissue engineering, Laser, bioprinting, skin, and cell therapy

Type: Startup Activities: deeptech biotech manufacturing Technologies: 3D Printing Synthetic Biology

12 8 5 22
ADDIDREAM ADDIDREAM

ADDIDREAM is a french company dedicated to the medical additive manufacturing. Thanks to a 550 m2 production area of different medical adapted 3D printing technology, we offer innovate solutions for the healthcare industry. Our services include computing aided design (CAO), different types of biocompatible materials 3D printing, and post-treatment processes.

Type: Startup Activities: deeptech healthtech Industry 4.0 manufacturing Technologies: 3D Printing Synthetic Biology

5 5 0 10
Dyameo Dyameo

[Automatic translation follows] Dyameo is a research & development in the field of medical devices which designs probes to aid in the diagnosis of cancer cells in-vivo. This medical device allows us to answer the question: “Are these cells cancerous?”, in a simple, clear and instantaneous way. This breakthrough solution proposes to discriminate cancer cells at an early stage, during endoscopic examinations. Medical devices, MedTech, and In-vivo cancer diagnosis assistance

Type: Startup Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

2 2 0 8
Genbiotech Genbiotech

Bringing People & Ressources Together The creation of Genbiotech, a spinoff of the Laboratoires Genévrier results of 15 years of strategic involvement in biotechnological research with one goal: to improve the quality of life of patients in the field of rheumatology, dermatology and aesthetic. We believe that tomorrow medicine needs to be dedicated and targeted to patients. We aim to improve existing treatments by using non invasive processes allowing local and sustained administration of biological and active molécules. The company, incepted in 1998, has currently a staff of 11 people and is located in Sophia Antipolis (South of France). For …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

1 1 0 8
Smart Immune Smart Immune

Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

21 12 11 40
EVerZom EVerZom

Revolutionizing healthcare with exosomes focusing on gastrointestinal, liver and kidney regeneration EverZom is an exosome biotech company developing treatments for digestive tissue healing like Crohn's fistula and organ regeneration like the kidney and the liver. Founded in 2019, EverZom is positioned to become the leader of exosome therapeutics, the next wave of innovation for the biotech industry. Exosomes, small vesicles secreted by cells, are increasingly recognized as potent agents for intercellular communication and play a crucial role to treat a wide range of diseases. Winner of the European EIC Accelerator Program, EVerZom aims to be the upcoming pioneer in this …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

12 12 0 18
MAD-UP MAD-UP

Rehabilitation, Physiotherapy, Sports, New technologies, Seniors. Functional rehabilitation without the time constraints and risks of intense effort. MAD-UP Pro is a fast and individualized rehabilitation and muscle strengthening solution. Health professionals can rely on an innovative tool, the only one capable of regulating the pressure applied to a muscle during exercise. By adapting the blood flow restriction training process (BFR Training), MAD-UP Pro secures a practice already scientifically recognized and medically validated. BFR by MAD-UP introduces a new therapeutic practice and improves patient progress. Whatever the pathologies, the device assists physiotherapists in an optimal and safe way. In order to …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

7 1 3 12
Gravipack® Gravipack®

[Automatic translation follows] The backpack that takes the strain off your shoulders. The weight is distributed over the center of gravity of the body. I created an extraordinary innovation: an exoskeleton that lightens the load on the shoulders and back. Discover GRAVIPACK, the ultimate solution to solve the major problem of pressure on the shoulders, thorax and arms. GRAVIPACK is the only shoulder strap system in the world that distributes weight across the human body's center of gravity, providing a feeling of lightness and combating musculoskeletal disorders (MSD). 🔝🩺IMPROVED HEALTH Frees the natural movement of the arms. Maintain an upright …

Type: Startup Activities: healthtech Technologies: Synthetic Biology

33 1 32 4
Cryonic Medical Cryonic Medical

Cryonic designs, develops and manufactures localised cryotherapy medical devices for health and aesthetics applications. Cryonic Medical invented the hyperbaric gaseous cryotherapy for the treatment of pain, inflammation and vascular disorder used by world champions Novak Djokovic, London Olympic Games, Equipe de France de Rugby Cryonic Medical is the worlwide leader in hyperbaric gaseous cryotherapy. Cryonic Medical offers a rapid, pain-free, non-invasive and efficient method to treat pain by leveraging the thermal shock. The thermal shock reaction allows the treatment of pain or inflammation within seconds and without the need of any medication. We called this method NeuroCryoStimulation (c) or NCS. …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

1 0 1 5
Planktovie Planktovie

Innovation for Aquatic Animal Research Planktovie’s vision is to develop planktonic nutritional solutions meeting the highest standards for the maintenance of your aquatic animal models, and helping to fulfill the 3Rs (Reduce, Refine, Replace the use of animals for scientific purposes) concept (http://www.nc3rs.org.uk/). Aquatic animal models are gaining in importance as alternatives to more conventional models such as rodents. The use of zebrafish is rapidly expanding in both basic and applied research in areas such as clinical research, pharmacology, and drug discovery. The husbandry requirements of zebrafish, and especially their nutritional needs, have a massive impact on both the number …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 2 5 4
HMT HMT

[Automatic translation follows] Work different - Work differently HMT supports all organizations of all sizes in their prevention approach to improve working conditions and limit the risks of the appearance of occupational diseases (MSD, RPS, etc.). Based on an ergonomic approach, our multidisciplinary team helps you identify, propose and integrate technical and organizational solutions that meet your projects. Our design office can also co-design and manufacture, in Tarbes, technical solutions specific to your activities. Mechanics, IT, Electronics, Handling, Exoskeleton, Design, Production, Study, and Ergonomics

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

17 0 17 37
BioIntrant BioIntrant

[Automatic translation follows] Probiotic Agriculture: improving agricultural productivity through plant health BioIntrant integrates more than thirty years of research at the interface of agronomy, pedology, microbial ecology and bioinformatics, in order to develop biostimulants for modern and responsible agriculture. To do this, BioIntrant integrates the plant into its environment (plant triptych, soil structure, microorganisms) to promote its intrinsic capacity to defend itself. It is today possible, thanks to the most advanced technologies and knowledge of the microbial ecology of plants, to restore this natural balance. Biotechnology, Agriculture, Agronomy, Microbiology, Biostimulant, Bioinformatics, and Genomics

Type: Startup Activities: agritech biotech deeptech Technologies: Synthetic Biology

10 2 9 4
Molsid Molsid

Time is Life. We develop life saving AMR diagnostics that are fast and reliable. Innovative BioMed company, developing a new generation of fluorogenic molecular probes, for applications such as rapid medical diagnostics, drug discovery and medical imaging, but also food quality control. Based on over 15 years of R&D at the prestigious ENS University de Lyon, Molsid’s patented SmartID technology is considered a breakthrough in high quality identification of enzyme activity in live cells. Molsid offers the broadest range of robust fluorogenic precipitation-based probes available on the market. We offer unsurpassed fast and sensitive fluorescence detection for a large panel …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

7 2 5 14
4P-Pharma 4P-Pharma

Established in 2014, 4P-Pharma is a clinical-stage biotech company dedicated to addressing serious diseases with significant unmet medical needs. Our goal is to bring first-in-class therapies to patients swiftly.​ Our core is a specialized R&D engine that enhances risk management and accelerates the development process, effectively cutting down on time, costs, and uncertainty.​ We focus on developing assets combining rapid time to market and solid intellectual property. Our strategy leverages cutting-edge clinical trial designs and expedited regulatory pathways to bring our therapies to those in need as quickly as possible. Translational research, Biotechnology, Pharmaceuticals, Inflammation, Abuse deterrent formulations, Research and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

6 2 4 30
Apmonia Therapeutics Apmonia Therapeutics

Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1). Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1. immunologie and oncologie

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

13 6 10 16
e-Zyvec e-Zyvec

e-Zyvec services by Polyplus provide tailor-made plasmids that really fit your needs! e-Zyvec is a French Biotech Start-up founded in 2016 as a spin-off of the University of Lille 1. We are providing unique solutions in molecular biology to academical or industrial scientists working on research project with genetic engineering applications. Using our proprietary DNA assembly technology and our in-house developped web application, we can design and produce fully customized gene expression vectors, fitting exactly the requirements of your project. Getting vectors with e-zyvec is fast, accurate and unrestrictive. Molecular Biology and Genetic Enginnering

Type: Startup Activities: deeptech manufacturing Technologies: Synthetic Biology

1 0 0 4
Cilcare Cilcare

MAKING HEARING A PRIORITY CILCARE is a biotech dedicated to harnessing auditory sciences to reshape the future of care via early diagnosis and targeted treatment. We believe hearing acts as a valuable indicator of our health and must be monitored and preserved accordingly. As awareness of the link between hearing and chronic health conditions grows, auditory sciences are paving the way for the early detection of chronic neurocognitive, inflammatory, and age-related diseases. CILCARE External Innovation supports its partners in the health and life-sciences sector in the development of new therapies to prevent and treat auditory-related diseases including inherited hearing loss, …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

32 11 27 33
IDMED IDMED

Innovative technology, safer outcomes. IDMED develops and markets medical devices in the field of anaesthesia that are used in operating room and intensive care units around the world. Two range of products are available for the customers: pupillometry and neuromuscular transmission monitoring. More than 15 years’ experience in the field of ocular movements assessment has led IDMED to develop innovative medical devices that monitors the pupil and its reflexes to light or to noxious stimulation. With the AlgiScan and the MAPstation anaesthetists are able to assess the depth of analgesia while the NeuroLight gives indication of the Pupillary Light Reflex …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

4 3 2 23
PhysioAssist PhysioAssist

[Automatic translation follows] PhysioAssist develops and markets Simeox, an innovative airway clearance device for patients with CF, COPD, BE PhysioAssist is a medical equipment company that has developed expertise in rheology, the study of the physics of bronchial mucus. After several years of research, an effective pneumatic vibration signal was characterized to act on intrapulmonary mucus, liquefying it and draining it. This signal is delivered by the Simeox medical device, which stimulates the bronchial mucus by successive depressions, while ensuring passive expiration. Simeox is intended for patients with chronic respiratory pathologies. COPD, airway clearance, respiratory device, and cystic fibrosis

Type: Startup Activities: healthtech deeptech manufacturing Technologies: Synthetic Biology

6 4 0 17
FineHeart FineHeart

A Healthier Life With Every Beat FineHeart is a clinical stage medical device company based in Bordeaux, France. Its innovative product, FLOWMAKER®, has the potential to treat 200,000 patients with advanced heart failure each year. FineHeart will initially target the 50,000 most severe patients who are eligible for cardiac assistance. Initial estimates value this market segment to be worth over US$5 billion. FineHeart was founded by CEO Arnaud Mascarell and a team of internationally renowned cardiac surgeons and electro-physiologists, including Dr. Stephane Garrigue, CSO and inventor of the concept, and Dr. Philippe Ritter, co-inventor of cardiac resynchronization therapy (CRT). The …

Type: Startup Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

25 6 21 71
Coave Therapeutics Coave Therapeutics

Coave therapeutics new brand for Horama Coave Therapeutics is a clinical stage biotechnology company focused on developing life changing gene therapies in rare Ocular and CNS (Central Nervous System) diseases. We are pushing the boundaries of gene therapy through application of our AAV-Ligand Conjugates platform (ALIGATER) that enables targeted delivery, enhanced gene transduction and tissue distribution to improve the effectiveness of advanced gene therapies for rare diseases. Our strategy is to advance a pipeline of novel therapies targeting rare ocular and CNS diseases where targeted gene therapy has the potential to be most effective, where there is a clear unmet …

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

4 2 1 39
Redberry SAS Redberry SAS

Industrial microbiology testing providing immediate results at performance and ease-of-use never reached before. Redberry develops a new platform aimed at avoiding the culture phase of microorganisms in industrial microbiology and thus providing immediate results at cost, performance and ease-of-use never reached before. Microbiology and Diagnostics

Type: Startup Activities: deeptech Technologies: Synthetic Biology

18 8 15 14
CEMENTIC CEMENTIC

Nano-Life Innovations Cementic, founded in 2016, is a pioneering biotech startup with bases in Paris, France, and Palo Alto, USA. Specializing in cutting-edge nano-biotechnology solutions, our focus is on revolutionizing healthcare through innovative applications in dental care, orthopedics, and stem cell research. We leverage new paradigms to address complex health challenges, advancing global health from our dual locations. Medtech, Biotech, Dental, Orthopedics, Nanotechnolgies, Stem cells , and Liposomes

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 2
AlgoTx AlgoTx

AlgoTx develops novel therapeutic solutions for complex pain AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is based on a topical reformulation of amitriptyline with two lead indications of high unmet need that lead to unbearable pain in patient’s extremities and for which there are currently no viable treatment options. ATX01 targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. Its topical administration provides targeted pain relief from the excruciating pain in patient’s extremities for its two lead …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

4 3 2 13
Implanet Implanet

The permanent balance Based near Bordeaux (FR), IMPLANET is an international company with a US subsidiary in Boston, funded by European institutional and private investors. IMPLANET focuses on spine and knee products. Its flagship product, the JazzTM latest generation implant, is intended to improve the treatment of spinal disorders requiring spinal fusion surgery. Protected by 4 sets of international patents, JazzTM has obtained 510(k) clearance from the Food and Drug Administration (FDA) in the United States and the CE mark. Taking into account the evolution of the global healthcare system, the IMPLANET Marketing team identifies a portfolio of products and …

Type: Startup Activities: healthtech manufacturing Technologies: Synthetic Biology

0 0 0 43
Laverock Therapeutics Laverock Therapeutics

Next generation programmable cell therapies Next generation programmable cell therapies

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

1 0 1 31
Transimmune AG Transimmune AG

Restoring immune surveillance through natural immunity - a revolution in dendritic cell therapy. Transimmune AG is leading a revolution in dendritic cell therapy having uncovered how dendritic cells are made physiologically in vivo.

Type: Startup Activities: deeptech Technologies: Synthetic Biology

0 0 0 3
Physiogenex Physiogenex

Leading preclinical CRO specializing in metabolic disorders. Physiogenex is a leading preclinical research organization (CRO) specializing in metabolic disorders such as diabetes, insulin resistance, obesity, fatty liver (NASH / NAFLD), dyslipidemia, atherosclerosis and cardiovascular complications. We provide: - Classical and proprietary diet-induced in vivo models - Innovative in-house techniques (RCT) and gold standard methods (glucose clamps with radiolabelled tracers, ...) - In vivo preclinical imaging services Our models and technologies are customized and we deliver unparalleled scientific expertise for R&D, preclinical development, post-marketing studies and drug repositioning. We provide both the biopharmaceutical and nutraceutical companies with optimal and reliable solutions …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

4 1 2 20
Fresenius Kabi FR Fresenius Kabi FR

[Automatic translation follows] Fresenius Kabi is a global healthcare company specializing in life-saving medicines and medical devices in infusion, transfusion and clinical nutrition. Fresenius Kabi's medicines, technologies and services are used to help care for patients in emergency situations or with chronic illnesses. Fresenius Kabi's product portfolio includes a full range of generic intravenous medications, infusion therapies, clinical nutrition products as well as the medical devices required to administer these products. In the biosimilars space, we focus on autoimmune diseases and oncology. In 2019, Fresenius Kabi's first biosimilar product was launched. In the field of transfusion medicine and cell therapies, …

Type: SMB Activities: biotech deeptech healthtech Technologies: Synthetic Biology

8 1 7 448
Sonoscanner - Premium Ultrasound Scanners Sonoscanner - Premium Ultrasound Scanners

[Automatic translation follows] Premium Diagnostic Ultrasound ➡ Are you doctors or health practitioners? ➡ Do you practice ultrasound or would you like to integrate ultrasound into your daily practice? Benefit from Sonoscanner ultrasound machines, made in France! At Sonoscanner, a French manufacturer of ultrasound machines, we believe that every doctor deserves the best in innovation and support to establish precise diagnoses while enjoying their practice. More than 4,400 doctors perform ultrasound daily thanks to Sonoscanner. Our range is based around 3 models of ultrasound machines, to adapt perfectly to your needs. ✅ Portable ✅ Ultra-portable ✅ Stationary Our ultrasound systems …

Type: SMB Activities: deeptech healthtech manufacturing Technologies: Synthetic Biology

3 1 2 32